Source: International Congress 2019 – Involvement of the environment and inflammation in pulmonary remodelling
Disease area: Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
A. Boots (Maastricht, Netherlands), C. Albrecht (Duesseldorf, Germany), F. Van Schooten (Maastricht, Netherlands), R. Schins (Duesseldorf, Germany). Multi-walled carbon nanotubes elicit sustained pulmonary remodelling depending on gender rather than a functional Nrf2 status. 2441

Member's Comments

No comment yet.

Related content which might interest you: Enhanced adverse health effects upon in vivo exposure to multi-walled carbon nanotubes in chronic obstructive pulmonary disease Source: International Congress 2018 – COPD: immune regulation and therapeutic targets Year: 2018 Probing the carcinogenic potential of carbon nanotubes Source: Annual Congress 2009 - Biological and clinical markers in lung cancer Year: 2009 Effect of surface functionalisation on the interaction of carbon nanotubes with primary human alveolar cells in vitro. Source: International Congress 2017 – New insights into pathogenesis of lung disease  Year: 2017 Airway region-specific effects of carbon black nanoparticles (CBNP) Source: Annual Congress 2012 - Molecular biology of pro- and anti-inflammatory responses in the lung Year: 2012 Inhalation of carbon nanotubes will not necessarily induce mesothelioma: the two faces of Janus Source: Annual Congress 2010 - Mesothelioma and engineered nanotubes: cause for concern? Year: 2010 The effect of ferric oxide nanoparticles on pulmonary morphology, redox system and some immune components Source: Annual Congress 2007 - Advances in respiratory mechanics Year: 2007 Lung inflammation promotes arterial thrombosis via P-selectin: a study with carbon nanotubes in mice Source: Eur Respir J 2006; 28: Suppl. 50, 618s Year: 2006 The TL,NO/TL,CO ratio in pulmonary function test interpretation Source: Eur Respir J 2013; 41: 453-461 Year: 2013 Predicting survival in COPD using the transfer factor for carbon monoxide Z-score Source: Virtual Congress 2020 – Lung function tests and exhaled biomarkers Year: 2020 Carbon monoxide diffusing capacity and the complexity of diagnosis in pulmonary arterial hypertension Source: Eur Respir J 2014; 43: 963-965 Year: 2014 The lung and carbon dioxide: implications for permissive and therapeutic hypercapnia Source: Eur Respir J 2002; 20: 6-11 Year: 2002 Adjusting diffusing capacity of the lung for carbon monoxide for haemoglobin level Source: Eur Respir J 2013; 41: 489 Year: 2013 Influence of ventilation inhomogeneity on diffusing capacity of carbon monoxide in smokers without COPD Source: ERJ Open Res, 7 (1) 00706-2020; 10.1183/23120541.00706-2020 Year: 2021 The acute impact of exercise test on exhaled carbon monoxide rate Source: International Congress 2017 – Assessing functional outcomes in respiratory physiotherapy Year: 2017 Diffusing capacity for nitric oxide and carbon monoxide in patients with diffuse parenchymal lung disease and pulmonary arterial hypertension Source: Eur Respir J 2005; 26: Suppl. 49, 268s Year: 2005 Diffusing capacity of the lung for nitric oxide and carbon monoxide: Influence of alveolar volume Source: Annual Congress 2010 - Advances in lung function I Year: 2010 Impact of atrial septal defect closure on diffusing capacity for nitric oxide and carbon monoxide Source: ERJ Open Res, 5 (2) 00260-2018; 10.1183/23120541.00260-2018 Year: 2019 The relationship between transfer coefficient for carbon monoxide (KCO), weight and biochemical and morphological parameters in pulmonary emphysema Source: Eur Respir J 2004; 24: Suppl. 48, 122s Year: 2004